A Pharmacokinetic Rationale for Proactive Therapeutic Drug Monitoring of Anti-TNF Drugs Response

被引：0
|
作者：
Papamichael, Konstantinos [1 ]
Cheifetz, Adam S. [1 ]
机构：
[1] Harvard Med Sch, Div Gastroenterol, Dept Med, Ctr Inflammatory Bowel Dis, Boston, MA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2017年 / 112卷 / 12期
关键词：
INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; INFLIXIMAB; IBD;
D O I：
10.1038/ajg.2017.375
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1893 / 1894
页数：2
相关论文
共 50 条
  • [11] Therapeutic drug monitoring of anti-TNF therapy in children with inflammatory bowel disease
    van Hoeve, Karen
    Hoffman, Ilse
    Vermeire, Severine
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (02) : 185 - 196
  • [12] A UK National Survey of Therapeutic Drug Monitoring With Anti-TNF Medications in IBD
    Nayeemuddin, Shadab
    Nigam, Gaurav B.
    Kontopantelis, Evangelos
    Hayee, Bu
    Limdi, Jimmy K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S443 - S443
  • [13] Is anti-TNF therapeutic drug monitoring of value in IBD patients in clinical remission?
    Subramaniam, K.
    Watthayalage, R.
    Neeman, T.
    Pavli, P.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S353 - S353
  • [14] Management of loss of response to anti-TNF drugs: Change the dose or change the drug?
    Van Assche, Gert
    Vermeire, Severine
    Rutgeerts, Paul
    JOURNAL OF CROHNS & COLITIS, 2008, 2 (04): : 348 - 351
  • [15] The rationale for the current boom in anti-TNFα treatment.: Is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNFα and minimise hazards?
    Feldmann, M
    Bondeson, J
    Brennan, FM
    Foxwell, BMJ
    Maini, RN
    ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 : 27 - 31
  • [16] Effect of a Practice-wide Anti-TNF Proactive Therapeutic Drug Monitoring Program on Outcomes in Pediatric Patients with Inflammatory Bowel Disease
    Lyles, John L.
    Mulgund, Aditi A.
    Bauman, Laura E.
    Su, Weizhe
    Fei, Lin
    Chona, Deepika L.
    Sharma, Puneet
    Etter, Renee K.
    Hellmann, Jennifer
    Denson, Lee A.
    Minar, Phillip
    Dykes, Dana M.
    Rosen, Michael J.
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (04) : 482 - 492
  • [17] Therapeutic Drug Monitoring of Anti-TNFα Inhibitors: A Matter of Cut-Off Ranges
    Cheli, Stefania
    Savino, Diego
    Penagini, Francesca
    Zuccotti, Gianvincenzo
    Zuin, Giovanna
    Clementi, Emilio
    Cattaneo, Dario
    PHARMACEUTICS, 2023, 15 (07)
  • [18] Is There a Role for Therapeutic Drug Monitoring of Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease
    Baert, Filip
    DIGESTIVE DISEASES, 2015, 33 : 70 - 77
  • [19] Therapeutic Drug Monitoring in IBD: The New Standard-of-Care for Anti-TNF Therapy
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (05): : 673 - 676
  • [20] Editorial: proactive anti-TNF drug monitoring in IBD--Ready for the prime time? Authors' reply
    Sethi, Sonika
    Kumar, Aditi
    Dias, Shiluka
    Blackwell, Jonathan
    Brookes, Matthew J.
    Segal, Jonathan P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (12) : 1455 - 1456
12345